Skip to main content
. 2020 Dec 13;12(5):580–587. doi: 10.1111/1759-7714.13777

Figure 1.

Figure 1

Frequency of driver mutations in Brazilian non‐small‐cell lung cancer (NSCLC). Mutation description was recovered from FoundationOne CDx and FoundationACT reports and calculated as a percentage of the total number of patients studied (N = 513) (Inline graphic) KRAS, (Inline graphic) EGFR, (Inline graphic) STK11, (Inline graphic) PI3K, (Inline graphic) ALK, (Inline graphic) BRAF, (Inline graphic) ERBB2, (Inline graphic) MET, (Inline graphic) RET, (Inline graphic) ROS, (Inline graphic) NTRK, (Inline graphic) Others.